Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Douglas A. McIntyre | Dec 15, 2006 at 1:33 AM EST

No Decisive Word on Encysive Pharmaceuticals

From BioHealth Investor Things aren’t looking good. I wrote about Encysive Pharmaceuticals (ENCY) on Friday after their stock jumped on…

Douglas A. McIntyre | Dec 15, 2006 at 1:32 AM EST

Thursday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology SHEFFIELD PHARMACTLS [SFPH.OB] +34.33% IMMTECH PHARM INC [IMM] +19.09% CYTORI THERAPEUTICS [CYTX] +9.96% VERNALIS PLC ADR…

Douglas A. McIntyre | Dec 14, 2006 at 4:26 AM EST

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology PROGEN INDS LTD [PGLA] +119.66% EXACT SCIENCES COR [EXAS] +12.89% ANADYS PHARMACEUTICA [ANDS] +7.29% ADVENTRX PHARMACTL…

Douglas A. McIntyre | Dec 14, 2006 at 4:25 AM EST

Australian Biotech Progen Industries Jumps 100%

From BioHealth Investor Shares of Progen Industries (PGLA) of Australia skyrocketed more than 100% on Wednesday, ending trading at $6.48…

Douglas A. McIntyre | Dec 14, 2006 at 4:23 AM EST

Insmed Loses Patent Case to Tercica; Companies Should Merge

From BioHealth Investor by Andrew Vaino As I mentioned last week in the Daily Blog, the patent case between Insmed…

Douglas A. McIntyre | Dec 13, 2006 at 11:36 AM EST

Ten Most Undervalued Stocks: Amgen

At below $70, Amgen (AMGN) trades back where it was in July, 2003, and well below its and well below…

Douglas A. McIntyre | Dec 13, 2006 at 4:23 AM EST

Tuesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology NUTRITION 21 INC [NXXI] +17.86% HALOZYME THERAPEUTIC [HTI] +12.74% BIONOVO INC [BNVI.OB] +12.50% DISCOVERY LABS INC…

Douglas A. McIntyre | Dec 13, 2006 at 4:21 AM EST

Adverse Events Reporting and Supplements

From BioHealth Investor by Mark S. Senak As reported earlier this week, S.3546 – the Dietary and Supplement and Nonprescription…

Douglas A. McIntyre | Dec 12, 2006 at 11:08 AM EST

Merck Wants Out Of Pfizer’s Shadow

Stocks: (MRK)(PFE) Merck, along with most Big Pharma, wants to get as far away from the blast of Pfizer’s failed…

Douglas A. McIntyre | Dec 12, 2006 at 3:01 AM EST

Does Congress Want You To Be Sick?

Stocks: (PFE)(MRK)(BMY) One of the by-products of the new Democratic controlled Congress is that Big Pharma companies are scared to…

Douglas A. McIntyre | Dec 11, 2006 at 8:58 AM EST

Cryolife Gaps Up to Recent Highs on FDA Approval

CryoLife, Inc., (CRY-NYSE) is trading up more than 5% pre-market after it announced that it has received 510(k) marketing approval…

Douglas A. McIntyre | Dec 11, 2006 at 5:16 AM EST

Hematology Meeting to Give Biotechs Boost Today

by H.S. AyoubBioHealthInvestor.com Monday looks to be a great day for biotech stocks as this past weekend saw a flurry…

Douglas A. McIntyre | Dec 10, 2006 at 11:32 AM EST

GlaxoSmithKline May Benefit from Weak U.S. Dollar

GlaxoSmithKline (GSK) is a pharmaceutical stock which has outperformed the S&P with less volatility, and which may also benefit if…

Douglas A. McIntyre | Dec 10, 2006 at 11:30 AM EST

Biotech & Medical Venture Deals Roundup

From BioHealth Investor by Adam Rubenstein NeoVista, Inc. (Fremont, CA), an ophthalmic device company focused on the treatment of age-related…

Douglas A. McIntyre | Dec 8, 2006 at 4:10 AM EST

Vanda Schizophrenia Drug Meets Phase III Endpoint

From BioHealth Investor by H.S. AyoubBioHealthInvestor.com Shares of Vanda Pharmaceuticals (VNDA) look to open much higher on Thursday as the…

1 … 388 389 390 391 392

Health and Healthcare Articles

All Health and Healthcare Articles

No Decisive Word on Encysive Pharmaceuticals

Thursday’s Top Biotech and Medical Stocks

Wednesday’s Top Biotech and Medical Stocks

Australian Biotech Progen Industries Jumps 100%

Insmed Loses Patent Case to Tercica; Companies Should Merge

Ten Most Undervalued Stocks: Amgen

Tuesday’s Top Biotech and Medical Stocks

Adverse Events Reporting and Supplements

Merck Wants Out Of Pfizer’s Shadow

Does Congress Want You To Be Sick?

Cryolife Gaps Up to Recent Highs on FDA Approval

Hematology Meeting to Give Biotechs Boost Today

GlaxoSmithKline May Benefit from Weak U.S. Dollar

Biotech & Medical Venture Deals Roundup

Vanda Schizophrenia Drug Meets Phase III Endpoint

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Apple Will Run Advanced AI Model on Nvidia GPUs via Google Cloud, Ditching Private Infrastructure

Will XRP Explode? The Rare RSI Signal That Preceded Every Major Rally Just Flashed Again

The Capex Signal That Will Make or Break IGPT in the Next 12 Months

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill

Apple Will Run Advanced AI Model on Nvidia GPUs via Google Cloud, Ditching Private Infrastructure

Will XRP Explode? The Rare RSI Signal That Preceded Every Major Rally Just Flashed Again

Health and Healthcare Articles

All Health and Healthcare Articles

No Decisive Word on Encysive Pharmaceuticals

Thursday’s Top Biotech and Medical Stocks

Wednesday’s Top Biotech and Medical Stocks

Australian Biotech Progen Industries Jumps 100%

Insmed Loses Patent Case to Tercica; Companies Should Merge

Ten Most Undervalued Stocks: Amgen

Tuesday’s Top Biotech and Medical Stocks

Adverse Events Reporting and Supplements

Merck Wants Out Of Pfizer’s Shadow

Does Congress Want You To Be Sick?

Cryolife Gaps Up to Recent Highs on FDA Approval

Hematology Meeting to Give Biotechs Boost Today

GlaxoSmithKline May Benefit from Weak U.S. Dollar

Biotech & Medical Venture Deals Roundup

Vanda Schizophrenia Drug Meets Phase III Endpoint

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Apple Will Run Advanced AI Model on Nvidia GPUs via Google Cloud, Ditching Private Infrastructure

Will XRP Explode? The Rare RSI Signal That Preceded Every Major Rally Just Flashed Again

The Capex Signal That Will Make or Break IGPT in the Next 12 Months

Featured Reads

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill